IL28B and the control of hepatitis C virus infection

Gastroenterology

Volumn 139, Issue 6, 2010, Pages 1865-1876

  Balagopal, Ashwin ^a   Thomas, David L ^a,b   Thio, Chloe L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

HCV Treatment; Hepatitis C Virus; IL28B; Interferon Lambda; Interferon Sensitivity

Indexed keywords

INTERFERON; INTERFERON LAMBDA 3; INTERLEUKIN 28; INTERLEUKIN 28B; INTERLEUKIN 29; PEGINTERFERON; RIBAVIRIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; CLINICAL ASSESSMENT; ENZYME INDUCTION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION CONTROL; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; VIRUS CLEARANCE; VIRUS REPLICATION;

EID: 78649708165     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.10.004     Document Type: Review

References (45)

1. L.E. Wilson, M. Torbenson, and J. Astemborski Progression of liver fibrosis among injection drug users with chronic hepatitis C Hepatology 43 2006 788 795
2. D.L. Thomas, J. Astemborski, and R.M. Rai The natural history of hepatitis C virus infection: host, viral, and environmental factors JAMA 284 2000 450 456
3. D.L. Thomas, and L.B. Seeff Natural history of hepatitis C Clin Liver Dis 9 2005 383 398 vi
4. H.H. Gad, C. Dellgren, and O.J. Hamming Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family J Biol Chem 284 2009 20869 20875
5. B.A. Fox, P.O. Sheppard, and P.J. O'Hara The role of genomic data in the discovery, annotation and evolutionary interpretation of the interferon-lambda family PLoS One 4 2009 e4933
6. M.D. Robek, B.S. Boyd, and F.V. Chisari Lambda interferon inhibits hepatitis B and C virus replication J Virol 79 2005 3851 3854
7. T. Marcello, A. Grakoui, and G. Barba-Spaeth Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics Gastroenterology 131 2006 1887 1898
8. N.E. Pagliaccetti, R. Eduardo, and S.H. Kleinstein Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication J Biol Chem 283 2008 30079 30089
9. A.J. Muir, M.L. Shiffman, and A. Zaman Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection Hepatology 52 2010 822 832
10. D. Ge, J. Fellay, and A.J. Thompson Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
11. J.J. McCarthy, J.H. Li, and A. Thompson Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin Gastroenterology 138 2010 2307 2314
12. V. Suppiah, M. Moldovan, and G. Ahlenstiel IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
13. Y. Tanaka, N. Nishida, and M. Sugiyama Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
14. A. Rauch, Z. Kutalik, and P. Descombes Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Gastroenterology 138 2010 1338 1345 1345.e1-7
15. D.L. Thomas, C.L. Thio, and M.P. Martin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
16. M.A. Montes-Cano, J.R. Garcia-Lozano, and C. Abad-Molina Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes Hepatology 52 2010 33 37
17. H.L. Tillmann, A.J. Thompson, and K. Patel A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice Gastroenterology 2010 Jul 14 [epub ahead of print]
18. K.K. Yan, M. Guirgis, and T. Dinh Treatment responses in Asians and Caucasians with chronic hepatitis C infection World J Gastroenterol 14 2008 3416 3420
19. C.H. Liu, C.J. Liu, and C.L. Lin Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial Clin Infect Dis 47 2008 1260 1269
20. A. Mangia, A.J. Thompson, and R. Santoro An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response Gastroenterology 139 2010 821 827
21. N.I. Rallon, S. Naggie, and J.M. Benito Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients AIDS 24 2010 F23 F29
22. Martin MP, Qi Y, Goedert JJ, et al. IL28B polymorphism does not determine hepatitis B virus or HIV outcomes. J Infect Dis (in press).
23. Y. Kamatani, S. Wattanapokayakit, and H. Ochi A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians Nat Genet 41 2009 591 595
24. J. Fellay, K.V. Shianna, and D. Ge A whole-genome association study of major determinants for host control of HIV-1 Science 317 2007 944 947
25. A.J. Thompson, A.J. Muir, and M.S.et a. Sulkowski Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus Gastroenterology 139 2010 120 129
26. M. Honda, A. Sakai, and T. Yamashita Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of interferon therapy for chronic hepatitis C Gastroenterology 139 2010 499 509
27. L. Chen, I. Borozan, and J. Feld Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection Gastroenterology 128 2005 1437 1444
28. M. Sarasin-Filipowicz, E.J. Oakeley, and F.H. Duong Interferon signaling and treatment outcome in chronic hepatitis C Proc Natl Acad Sci U S A 105 2008 7034 7039
29. N. Ank, H. West, and S.R. Paludan IFN-lambda: novel antiviral cytokines J Interferon Cytokine Res 26 2006 373 379
30. C. Sommereyns, S. Paul, and P. Staeheli IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo PLoS Pathog 4 2008 e1000017
31. W.J. Jordan, J. Eskdale, and S. Srinivas Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response Genes Immun 8 2007 254 261 (Pubitemid 46679436)
32. S. Srinivas, J. Dai, and J. Eskdale Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro Immunology 125 2008 492 502
33. M.P. Morrow, P. Pankhong, and D.J. Laddy Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity Blood 113 2009 5868 5877
34. K. Onoguchi, M. Yoneyama, and A. Takemura Viral infections activate types I and III interferon genes through a common mechanism J Biol Chem 282 2007 7576 7581
35. M. Mordstein, G. Kochs, and L. Dumoutier Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses PLoS Pathog 4 2008 e1000151
36. M. Mordstein, E. Neugebauer, and V. Ditt Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections J Virol 84 2010 5670 5677
37. N. Ank, H. West, and C. Bartholdy Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo J Virol 80 2006 4501 4509
38. C. Dellgren, H.H. Gad, and O.J. Hamming Human interferon-lambda3 is a potent member of the type III interferon family Genes Immun 10 2009 125 131
39. S.E. Doyle, H. Schreckhise, and K. Khuu-Duong Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes Hepatology 44 2006 896 906
40. W. Hou, X. Wang, and L. Ye Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages J Virol 83 2009 3834 3842
41. N. Ank, M.B. Iversen, and C. Bartholdy An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity J Immunol 180 2008 2474 2485
42. M.G. Ghany, D.B. Strader, and D.L. Thomas Diagnosis, management, and treatment of hepatitis C Hepatology 494 2009 1335 1374
43. J. Grebely, K. Petoumenos, and M. Hellard Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection Hepatology 52 2010 1216 1224
44. N. Akuta, F. Suzuki, and M. Hirakawa Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin Hepatology 52 2010 421 429
45. C.L. Thio, and D.L. Thomas Interleukin-28b: a key piece of the hepatitis C virus recovery puzzle Gastroenterology 138 2010 1240 1243